| Renal Artery Stenosis. | |
| | |
MedLine Citation:
|
PMID: 11341864 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Renal artery stenosis (RAS) can accelerate or generate progressive hypertension and renal dysfunction. The goals for treating patients with RAS are to reduce cardiovascular morbidity and mortality attributable to elevated arterial pressure and to preserve renal function beyond critical stenosis. Recent, randomized trials with current antihypertensive agents indicate that many patients with RAS can be managed for years without renal artery revascularization. As it does elsewhere, atherosclerotic disease can progress to more severe occlusion in the renal arteries. Rapid advances in endovascular techniques, including stenting, make restoration of renal blood flow possible in more patients than before. Therapeutic goals are achieved by 1) avoidance of tobacco, 2) reducing arterial pressure with antihypertensive drug therapy, particularly those agents capable of blocking the renin-angiotensin system, and 3) renal revascularization, using balloon angioplasty and stent placement, surgical bypass, or endarterectomy. The major clinical challenges are to identify progressive occlusive disease and to determine appropriate timing for vascular intervention. |
| | |
Authors:
|
Stephen C. Textor; Michael A. McKusick |
Related Documents
:
|
12469264 - A nephron-sparing surgical procedure for fraley's syndrome. a case report. 11383914 - Conn's syndrome and bilateral renal artery stenosis in the presence of multiple renal a... 7892464 - Renal artery aneurysm: treatment with percutaneous placement of a stent-graft. 11141654 - Selective embolization of a renal artery aneurysm. 121744 - The effect of overdistention of the lung on pulmonary function in beagle puppies. 6274234 - Absorbable suture materials for vascular anastomoses. tensile strength and axial pressu... |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Current treatment options in cardiovascular medicine Volume: 3 ISSN: 1534-3189 ISO Abbreviation: Curr Treat Options Cardiovasc Med Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-May-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815942 Medline TA: Curr Treat Options Cardiovasc Med Country: - |
Other Details:
|
Languages: ENG Pagination: 187-194 Citation Subset: - |
Affiliation:
|
Divisions of Hypertension and Nephrology, The Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA. textor.stephen@mayo.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Embolism from the Aorta: Atheroemboli and Thromboemboli.
Next Document: Mesenteric Vascular Disease.